The Ventilatory Stimulant Doxapram Inhibits TASK Tandem Pore (K2P) Potassium Channel Function but Does Not Affect Minimum Alveolar Anesthetic Concentration
Publication type: Journal Article
Publication date: 2006-02-14
scimago Q1
wos Q1
SJR: 1.161
CiteScore: 7.9
Impact factor: 3.8
ISSN: 00032999, 15267598
PubMed ID:
16492828
Anesthesiology and Pain Medicine
Abstract
TWIK-related acid-sensitive K(+)-1 (TASK-1 [KCNK3]) and TASK-3 (KCNK9) are tandem pore (K(2P)) potassium (K) channel subunits expressed in carotid bodies and the brainstem. Acidic pH values and hypoxia inhibit TASK-1 and TASK-3 channel function, and halothane enhances this function. These channels have putative roles in ventilatory regulation and volatile anesthetic mechanisms. Doxapram stimulates ventilation through an effect on carotid bodies, and we hypothesized that stimulation might result from inhibition of TASK-1 or TASK-3 K channel function. To address this, we expressed TASK-1, TASK-3, TASK-1/TASK-3 heterodimeric, and TASK-1/TASK-3 chimeric K channels in Xenopus oocytes and studied the effects of doxapram on their function. Doxapram inhibited TASK-1 (half-maximal effective concentration [EC50], 410 nM), TASK-3 (EC50, 37 microM), and TASK-1/TASK-3 heterodimeric channel function (EC50, 9 microM). Chimera studies suggested that the carboxy terminus of TASK-1 is important for doxapram inhibition. Other K2P channels required significantly larger concentrations for inhibition. To test the role of TASK-1 and TASK-3 in halothane-induced immobility, the minimum alveolar anesthetic concentration for halothane was determined and found unchanged in rats receiving doxapram by IV infusion. Our data indicate that TASK-1 and TASK-3 do not play a role in mediating the immobility produced by halothane, although they are plausible molecular targets for the ventilatory effects of doxapram.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
|
|
|
Anesthesia and Analgesia
3 publications, 4.17%
|
|
|
Pflugers Archiv European Journal of Physiology
3 publications, 4.17%
|
|
|
Russian Chemical Bulletin
2 publications, 2.78%
|
|
|
Journal of Molecular Biology
2 publications, 2.78%
|
|
|
Mendeleev Communications
2 publications, 2.78%
|
|
|
Journal of Neurophysiology
2 publications, 2.78%
|
|
|
Journal of Applied Physiology
2 publications, 2.78%
|
|
|
Handbook of Experimental Pharmacology
1 publication, 1.39%
|
|
|
Journal of Pharmacology and Experimental Therapeutics
1 publication, 1.39%
|
|
|
Molecular Pharmacology
1 publication, 1.39%
|
|
|
European Respiratory Journal
1 publication, 1.39%
|
|
|
Journal of Psychopharmacology
1 publication, 1.39%
|
|
|
Biomolecules
1 publication, 1.39%
|
|
|
Cells
1 publication, 1.39%
|
|
|
Frontiers in Pharmacology
1 publication, 1.39%
|
|
|
International Journal of Molecular Sciences
1 publication, 1.39%
|
|
|
NeuroSci
1 publication, 1.39%
|
|
|
Monatshefte fur Chemie
1 publication, 1.39%
|
|
|
Cellular and Molecular Neurobiology
1 publication, 1.39%
|
|
|
Translational Psychiatry
1 publication, 1.39%
|
|
|
Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology
1 publication, 1.39%
|
|
|
Seminars in Anesthesia, Perioperative Medicine and Pain
1 publication, 1.39%
|
|
|
Pharmacological Research
1 publication, 1.39%
|
|
|
Behavioural Brain Research
1 publication, 1.39%
|
|
|
Neuroscience Letters
1 publication, 1.39%
|
|
|
Experimental Neurology
1 publication, 1.39%
|
|
|
Respiratory Physiology and Neurobiology
1 publication, 1.39%
|
|
|
Anesthesiology Clinics
1 publication, 1.39%
|
|
|
Neuropharmacology
1 publication, 1.39%
|
|
|
1
2
3
|
Publishers
|
2
4
6
8
10
12
14
|
|
|
Elsevier
14 publications, 19.44%
|
|
|
Wiley
14 publications, 19.44%
|
|
|
Springer Nature
12 publications, 16.67%
|
|
|
MDPI
5 publications, 6.94%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
4 publications, 5.56%
|
|
|
American Physiological Society
4 publications, 5.56%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
2 publications, 2.78%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
2 publications, 2.78%
|
|
|
American Chemical Society (ACS)
2 publications, 2.78%
|
|
|
European Respiratory Society (ERS)
1 publication, 1.39%
|
|
|
SAGE
1 publication, 1.39%
|
|
|
Frontiers Media S.A.
1 publication, 1.39%
|
|
|
Cambridge University Press
1 publication, 1.39%
|
|
|
Taylor & Francis
1 publication, 1.39%
|
|
|
Oxford University Press
1 publication, 1.39%
|
|
|
BMJ
1 publication, 1.39%
|
|
|
American Association for the Advancement of Science (AAAS)
1 publication, 1.39%
|
|
|
American Society for Microbiology
1 publication, 1.39%
|
|
|
Annual Reviews
1 publication, 1.39%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 1.39%
|
|
|
American Society for Clinical Investigation
1 publication, 1.39%
|
|
|
IMR Press
1 publication, 1.39%
|
|
|
2
4
6
8
10
12
14
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
72
Total citations:
72
Citations from 2025:
1
(1.39%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Cotten J. F. et al. The Ventilatory Stimulant Doxapram Inhibits TASK Tandem Pore (K2P) Potassium Channel Function but Does Not Affect Minimum Alveolar Anesthetic Concentration // Anesthesia and Analgesia. 2006. Vol. 102. No. 3. pp. 779-785.
GOST all authors (up to 50)
Copy
Cotten J. F. The Ventilatory Stimulant Doxapram Inhibits TASK Tandem Pore (K2P) Potassium Channel Function but Does Not Affect Minimum Alveolar Anesthetic Concentration // Anesthesia and Analgesia. 2006. Vol. 102. No. 3. pp. 779-785.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1213/01.ane.0000194289.34345.63
UR - https://doi.org/10.1213/01.ane.0000194289.34345.63
TI - The Ventilatory Stimulant Doxapram Inhibits TASK Tandem Pore (K2P) Potassium Channel Function but Does Not Affect Minimum Alveolar Anesthetic Concentration
T2 - Anesthesia and Analgesia
AU - Cotten, Joseph F.
PY - 2006
DA - 2006/02/14
PB - Ovid Technologies (Wolters Kluwer Health)
SP - 779-785
IS - 3
VL - 102
PMID - 16492828
SN - 0003-2999
SN - 1526-7598
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2006_Cotten,
author = {Joseph F. Cotten},
title = {The Ventilatory Stimulant Doxapram Inhibits TASK Tandem Pore (K2P) Potassium Channel Function but Does Not Affect Minimum Alveolar Anesthetic Concentration},
journal = {Anesthesia and Analgesia},
year = {2006},
volume = {102},
publisher = {Ovid Technologies (Wolters Kluwer Health)},
month = {feb},
url = {https://doi.org/10.1213/01.ane.0000194289.34345.63},
number = {3},
pages = {779--785},
doi = {10.1213/01.ane.0000194289.34345.63}
}
Cite this
MLA
Copy
Cotten, Joseph F., et al. “The Ventilatory Stimulant Doxapram Inhibits TASK Tandem Pore (K2P) Potassium Channel Function but Does Not Affect Minimum Alveolar Anesthetic Concentration.” Anesthesia and Analgesia, vol. 102, no. 3, Feb. 2006, pp. 779-785. https://doi.org/10.1213/01.ane.0000194289.34345.63.